Company / Net Income
Sagimet Biosciences Inc. Net Income History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$27.9M
FY2024
5-year range
-$30.5M / -$27.9M
FY2023-FY2024
Trend
+8.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$28M in FY2024.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, net income increased 8.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$27.9M | +8.6% |
| FY2023 | -$30.5M | - |
As of FY2024 · SEC 10-K Annual Filings · Last checked Jun 28, 2026